TY - JOUR
T1 - The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy
AU - Peyromaure, Michaël
AU - Camparo, Philippe
AU - Badoual, Cécile
AU - Descazeaud, Aurélien
AU - Dinh-Xuan, Anh Tuan
PY - 2007/5/1
Y1 - 2007/5/1
N2 - OBJECTIVE: To analyse the prognostic value of vascular endothelial growth factor (VEGF) in men with clinically localized prostate cancer. PATIENTS AND METHODS: Paraffin wax-embedded sections from the radical prostatectomy (RP) specimens of 40 men operated for clinically localized prostate cancer were used to build tissue microarrays. Of these patients, 17 had cancer progression and bone metastases after RP (group 1), and 23 remained free-of-tumour recurrence after RP (group 2). VEGF-A expression was examined in the RP specimens using immunohistochemistry. RESULTS: The groups had similar tumour characteristics in terms of prostate-specific antigen level, Gleason score, and pathological stage. VEGF-A expression was significantly higher in group 1 than in group 2 (P = 0.046). In logistic regression analysis, VEGF-A expression was the most significant predictive factor of cancer progression after RP. CONCLUSION: VEGF-A expression in prostate cancer tissue is associated with the risk of cancer progression after RP. These results suggest that VEGF-A expression has a prognostic impact in clinically localized prostate cancer.
AB - OBJECTIVE: To analyse the prognostic value of vascular endothelial growth factor (VEGF) in men with clinically localized prostate cancer. PATIENTS AND METHODS: Paraffin wax-embedded sections from the radical prostatectomy (RP) specimens of 40 men operated for clinically localized prostate cancer were used to build tissue microarrays. Of these patients, 17 had cancer progression and bone metastases after RP (group 1), and 23 remained free-of-tumour recurrence after RP (group 2). VEGF-A expression was examined in the RP specimens using immunohistochemistry. RESULTS: The groups had similar tumour characteristics in terms of prostate-specific antigen level, Gleason score, and pathological stage. VEGF-A expression was significantly higher in group 1 than in group 2 (P = 0.046). In logistic regression analysis, VEGF-A expression was the most significant predictive factor of cancer progression after RP. CONCLUSION: VEGF-A expression in prostate cancer tissue is associated with the risk of cancer progression after RP. These results suggest that VEGF-A expression has a prognostic impact in clinically localized prostate cancer.
KW - Angiogenesis
KW - Prostate cancer
KW - Radical prostatectomy
KW - Vascular endothelial growth factor
UR - http://www.scopus.com/inward/record.url?scp=34247174730&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2007.06734.x
DO - 10.1111/j.1464-410X.2007.06734.x
M3 - Article
C2 - 17437444
AN - SCOPUS:34247174730
SN - 1464-4096
VL - 99
SP - 1150
EP - 1153
JO - BJU International
JF - BJU International
IS - 5
ER -